Drug intelligence / Profile preview

Xpansion

Development stage: Unknown
Lead developer: Giant Sports
Modality: Small Molecules

Overview

**Xpansion** is a multi-ingredient dietary supplement developed by **Giant Sports**, primarily marketed as a pre-workout "pump" formula. It is designed to enhance athletic performance by increasing nitric oxide (NO) production and promoting vasodilation. The formulation typically includes ingredients such as **citrulline malate**, **agmatine sulfate**, and **taurine**, which work synergistically to improve blood flow to working muscles, enhance nutrient delivery, and provide a "muscle pump" effect. Unlike many pre-workouts, Xpansion is often marketed as a stimulant-free or low-stimulant option, focusing on the physiological aspects of vasodilation rather than central nervous system stimulation. It is primarily indicated for individuals seeking to improve exercise performance and muscle fullness.

Brand names: Xpansion

Targets

NOS1 (nNOS)

Beyond the preview

Go deeper on Xpansion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xpansion.

Explore the full profile